NYSE: AVD
AMERICAN VANGUARD CORPCIK 0000005981 · SIC 2870 · Agricultural Chemicals
Mid
Revenue $515M
Assets $635M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
8-K
Filed Oct 1, 2026
· Period ending Oct 1, 2026
Summary not yet generated.
10-K/A
Filed Sep 30, 2026
· Period ending Dec 31, 2025
Disclosure removed
American Vanguard 10-K/A corrects auditor's report and accrued program costs; no change to financial results
3 material changes detected. Sign up free to read the summary.
Partner
Trade AVD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 11, 2026
· Period ending Aug 10, 2026
Summary not yet generated.
10-Q
Filed Aug 10, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Jun 8, 2026
· Period ending Jun 4, 2026
Summary not yet generated.
10-Q
Filed May 6, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
10-K
Filed Mar 16, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-K
Filed May 29, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
Latest financial statements
From 10-K/A filed Sep 30, 2026 (period ending Dec 31, 2025). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations
(In thousands, except per share data)
| Description | Years ended December 31, 2025 | Years ended December 31, 2024 | Years ended December 31, 2023 |
|---|---|---|---|
| Net sales | 515,114 | 547,306 | 579,371 |
| Cost of sales | (367,553) | (426,989) | (400,207) |
| Gross profit | 147,561 | 120,317 | 179,164 |
| Operating expenses | |||
| Selling, general and administrative | (110,633) | (119,634) | (116,887) |
| Research, product development and regulatory | (23,161) | (32,662) | (38,025) |
| Product liability claims | (9,730) | — | — |
| Transformation | (7,187) | (20,162) | (957) |
| Asset impairments | (25,395) | (50,414) | — |
| Gain from sale of assets | 249 | 1,000 | — |
| Operating (loss) income | (28,296) | (101,555) | 23,295 |
| Change in fair value of equity investments, net | (437) | (2,356) | (359) |
| Interest and other expenses, net | (18,470) | (16,547) | (12,639) |
| (Loss) income before provision for income taxes | (47,203) | (120,458) | 10,297 |
| Provision for income taxes | (2,679) | (5,882) | (2,778) |
| Net (loss) income | (49,882) | (126,340) | 7,519 |
| (Losses) earnings per common share—basic | (1.75) | (4.50) | 0.27 |
| (Losses) earnings per common share—assuming dilution | (1.75) | (4.50) | 0.26 |
| Weighted average shares outstanding—basic | 28,426 | 28,059 | 28,128 |
| Weighted average shares outstanding—assuming dilution | 28,426 | 28,059 | 28,533 |
Consolidated Balance Sheets
(In thousands, except share data)
| Description | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash | 12,425 | 12,514 |
| Receivables: | ||
| Trade, net of allowance for credit losses of $11,733 and $9,190 respectively | 160,511 | 169,743 |
| Other | 7,278 | 4,699 |
| Total receivables, net | 167,789 | 174,442 |
| Inventories | 176,034 | 179,292 |
| Prepaid expenses and other assets | 9,668 | 7,615 |
| Income taxes receivable | 4,606 | 5,030 |
| Total current assets | 370,522 | 378,893 |
| Property, plant and equipment, net | 53,036 | 58,169 |
| Operating lease right-of-use assets, net | 16,793 | 19,735 |
| Intangible assets, net | 138,746 | 150,497 |
| Goodwill | — | 19,701 |
| Deferred income tax assets | 2,637 | 1,242 |
| Other assets | 14,803 | 8,484 |
| Total assets | 596,537 | 636,721 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 87,505 | 69,159 |
| Customer prepayments | 33,094 | 52,675 |
| Accrued program costs | 52,227 | 69,449 |
| Accrued expenses and other payables | 28,261 | 31,989 |
| Operating lease liabilities, current | 5,765 | 6,136 |
| Income taxes payable | 2,594 | 2,942 |
| Total current liabilities | 209,446 | 232,350 |
| Long-term debt | 174,000 | 147,332 |
| Operating lease liabilities, long-term | 11,621 | 14,339 |
| Deferred income tax liabilities | 8,150 | 7,989 |
| Other liabilities | 923 | 1,601 |
| Total liabilities | 404,140 | 403,611 |
| Commitments and contingent liabilities (Notes 5 and 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued | — | — |
| Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,923,562 shares in 2025 and 34,794,548 shares in 2024 | 3,492 | 3,479 |
| Additional paid-in capital | 117,106 | 114,679 |
| Accumulated other comprehensive loss | (12,000) | (18,729) |
| Retained earnings | 155,000 | 204,882 |
| 263,598 | 304,311 | |
| Less treasury stock at cost, 5,915,182 shares in 2025 and 5,915,182 in 2024 | (71,201) | (71,201) |
| Total stockholders’ equity | 192,397 | 233,110 |
| Total liabilities and stockholders’ equity | 596,537 | 636,721 |
Consolidated Statements of Cash Flows
(In thousands)
| Description | Years ended December 31, 2025 | Years ended December 31, 2024 | Years ended December 31, 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net (loss) income | (49,882) | (126,340) | 7,519 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||
| Depreciation and amortization of property, plant and equipment and intangible assets | 18,742 | 22,322 | 21,780 |
| Amortization of other long-term assets | 21 | 226 | 1,754 |
| Amortization of deferred loan fees | 1,906 | 536 | 254 |
| Gain on disposal of property, plant and equipment | (75) | (1,000) | — |
| Impairment of assets | 25,395 | 50,414 | — |
| Provision for estimated credit losses | 2,360 | 2,319 | 1,935 |
| Stock-based compensation | 2,016 | 4,412 | 6,138 |
| Deferred income taxes | (1,351) | 1,452 | (9,710) |
| Changes in liabilities for uncertain tax positions or unrecognized tax benefits | (201) | (1,547) | (508) |
| Change in equity investment fair value | 437 | 2,356 | 359 |
| Lease obligations and non-cash lease expense, net | (147) | (37) | 256 |
| Unrealized foreign currency transaction (gains) losses | (193) | 804 | (581) |
| Changes in assets and liabilities associated with operations, net of business combinations: | |||
| Decrease (increase) in receivables | 7,697 | 7,481 | (20,278) |
| Decrease (increase) in inventories | 6,287 | 35,178 | (27,315) |
| Decrease (increase) in income tax receivable/payable | (9) | (3,775) | 3,568 |
| (Increase) decrease in prepaid expenses and other assets | (8,638) | (687) | 1,269 |
| Increase (decrease) in accounts payable | 15,434 | 3,714 | (2,287) |
| Decrease in customer prepayments | (19,582) | (12,882) | (45,079) |
| (Decrease) increase in accrued program costs | (17,384) | 1,775 | 7,244 |
| (Decrease) increase in accrued expenses and other payables | (4,024) | 17,202 | (5,066) |
| Net cash (used in) provided by operating activities | (21,191) | 3,923 | (58,748) |
| Cash flows from investing activities: | |||
| Capital expenditures | (3,919) | (7,279) | (11,878) |
| Proceeds from disposal of property, plant and equipment | 477 | 1,065 | 242 |
| Acquisitions of business and product line, net of cash acquired | — | — | (5,195) |
| Intangible assets | (165) | (409) | (186) |
| Net cash used in investing activities | (3,607) | (6,623) | (17,017) |
| Cash flows from financing activities: | |||
| Payments under line of credit agreement | (223,465) | (294,356) | (172,500) |
| Borrowings under line of credit agreement | 250,134 | 302,787 | 259,100 |
| Payment of deferred loan fees | (3,389) | (850) | — |
| Net receipt from the issuance of common stock under ESPP | 629 | 901 | 981 |
| Net (payment) receipt from the exercise of stock options | (205) | — | 46 |
| Payment from common stock purchased for tax withholding | — | (1,432) | (1,967) |
| Repurchase of common stock | — | — | (15,539) |
| Payment of cash dividends | — | (2,510) | (3,384) |
| Net cash provided by financing activities | 23,704 | 4,540 | 66,737 |
| Net increase (decrease) in cash | (1,094) | 1,840 | (9,028) |
| Effect of exchange rate changes on cash | 1,005 | (742) | 116 |
| Cash at beginning of year | 12,514 | 11,416 | 20,328 |
| Cash at end of year | 12,425 | 12,514 | 11,416 |
Amounts as printed on the EDGAR/iXBRL face — (In thousands, except per share data); (In thousands, except share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗